| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/07/2013 | US8435532 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis |
| 05/07/2013 | US8435509 Creation of a biological atrioventricular bypass to compensate for atrioventricular block |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/07/2013 | CA2620553C Therapeutic agent for hypertension |
| 05/07/2013 | CA2554071C A-type procyanidins useful in the treatment of nitric oxide mediated disorders |
| 05/07/2013 | CA2529154C Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 05/07/2013 | CA2514100C Carboxamide derivatives and the use thereof as factor xa inhibitors |
| 05/07/2013 | CA2467053C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/07/2013 | CA2459562C Synthetic heparin pentasaccharides |
| 05/02/2013 | WO2013063331A1 Agents, methods, and devices for affecting nerve function |
| 05/02/2013 | WO2013063217A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | WO2013063004A1 Device and method for sustained release of therapeutic agent |
| 05/02/2013 | WO2013062489A1 Lymphatic vessel endothelial hyaluronic acid receptor-1 (lyve-1+) macrophages and uses thereof |
| 05/02/2013 | WO2013062441A1 Pharmaceutical combination of atorvastatin and nicergoline for the prophylaxis or treatment of disorders of the cerebral circulation |
| 05/02/2013 | WO2013062332A2 Vascular anti-aging composition including syringaresinol |
| 05/02/2013 | WO2013062316A2 Composition containing modafinil or the derivatives thereof for treating vascular diseases or kca3.1-channel-mediated diseases |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | WO2013061977A1 Heterocycle derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | WO2013060887A1 A polypeptide for the protection against heart ischemia-reperfusion injury |
| 05/02/2013 | WO2013060751A1 Novel pyrazine derivatives |
| 05/02/2013 | WO2013060673A1 Quinone based nitric oxide donating compounds |
| 05/02/2013 | WO2013060636A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| 05/02/2013 | WO2013060303A1 Polypeptides inhibiting neovascularization and uses thereof |
| 05/02/2013 | WO2013060097A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof |
| 05/02/2013 | WO2013059879A1 Compositions and methods for the treatment of fibrosis and fibrotic diseases |
| 05/02/2013 | WO2013036610A3 Compositions comprising mg53 and methods for the treatment and prevention of airway injury |
| 05/02/2013 | WO2013025984A3 Cannabinoid receptor treatments |
| 05/02/2013 | WO2012174262A9 Formulations and methods of treating subjects having central nervous system, endocrine, inflammatory or cardiovascular disorders or at-risk thereof with highly purified omega-3 fatty acid formulations |
| 05/02/2013 | WO2012135868A8 Compositions and methods for the treatment and prevention of cardiac ischemic injury |
| 05/02/2013 | US20130109720 Indole inhibitors of crac |
| 05/02/2013 | US20130109702 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |
| 05/02/2013 | US20130109668 Azetidine compounds, compositions and methods of use |
| 05/02/2013 | US20130109665 Novel pyrazine derivatives |
| 05/02/2013 | US20130109649 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | US20130109639 Neprilysin inhibitors |
| 05/02/2013 | US20130109624 Novel neurotrophic factors |
| 05/02/2013 | US20130109614 Antagonists for diseases induced by cells with high-affinity elr-cxc chemokine receptor proteins |
| 05/02/2013 | US20130108694 Dry blend formulation of tetrahydrobiopterin |
| 05/02/2013 | US20130108672 Pharmaceutical compositions for substituted quinazolinones |
| 05/02/2013 | US20130108550 Bioabsorbable Co-Filler for Cerebrovascular Aneurysms |
| 05/02/2013 | CA2853466A1 Agents, methods, and devices for affecting nerve function |
| 05/02/2013 | CA2853347A1 Device and method for sustained release of therapeutic agent |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/02/2013 | CA2852743A1 Fused bicyclic oxazolidinone cetp inhibitor |
| 05/02/2013 | CA2852627A1 Heterocyclic derivative having pgd2 receptor antagonist activity |
| 05/02/2013 | CA2851930A1 Novel pyrazine derivatives |
| 05/02/2013 | CA2839390A1 Quinone based nitric oxide donating compounds |
| 05/01/2013 | EP2586774A1 Method for preparation of ranolazine |
| 05/01/2013 | EP2586452A1 Use of a chinese medicine composition in preparing medicaments for treating secondary prevention of myocardial infarction |
| 05/01/2013 | EP2586442A1 Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 05/01/2013 | EP2586441A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 05/01/2013 | EP2586435A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/01/2013 | EP2586434A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/01/2013 | EP2586433A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/01/2013 | EP2586305A1 Use of neuregulin for organ preservation |
| 05/01/2013 | EP2585592A2 Compositions and methods for re-programming cells without genetic modification for treatment of cardiovascular diseases |
| 05/01/2013 | EP2585583A2 Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof |
| 05/01/2013 | EP2585469A1 Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 05/01/2013 | EP2585439A1 Heterocyclic compounds, their preparation and their therapeutic application |
| 05/01/2013 | EP2585437A2 Thioacetate compounds, compositions and methods of use |
| 05/01/2013 | EP2585112A1 Collagen-binding synthetic peptidoglycans for use in vascular intervention |
| 05/01/2013 | EP2585053A2 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| 05/01/2013 | CN103080136A Anti-Axl antibodies and methods of use |
| 05/01/2013 | CN103080095A Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 05/01/2013 | CN103079565A Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors |
| 05/01/2013 | CN103079554A Treatment of hypertension and/or prevention or treatment of heart failure in a mammal receiving anti-coagulant therapy |
| 05/01/2013 | CN103073653A Biological enzymatic hydrolysis extraction method of coronary disease relieving component |
| 05/01/2013 | CN103073620A KDR peptides and vaccines comprising the same |
| 05/01/2013 | CN103073557A Benzophenanthridine alkaloid and application of benzophenanthridine alkaloid in resisting cardiovascular system diseases |
| 05/01/2013 | CN103073554A Substituted pyrrole chromone compound |
| 05/01/2013 | CN103073508A Kinase inhibitor and method for treating related diseases |
| 05/01/2013 | CN103073455A Novel KCNQ potassium channel agonist, and preparation method and application thereof |
| 05/01/2013 | CN103071152A Atherosclerotic vaccine |
| 05/01/2013 | CN103071136A Traditional Chinese medicine health care product capable of regulating yin and yang balance of human bodies and preparation method of traditional Chinese medicine health care product |
| 05/01/2013 | CN103071124A Chinese medicine formulae for treating cerebral infarction |
| 05/01/2013 | CN103071115A Traditional Chinese medicine preparation for treating coronary sclerosis |
| 05/01/2013 | CN103071111A Medicine composition for curing angina pectoris and preparation method of pharmaceutical composition |
| 05/01/2013 | CN103071078A Traditional Chinese medicinal composition for treating viral myocarditis |
| 05/01/2013 | CN103071067A Hibiscus mutabilis pill for strengthening body resistance and removing blood stasis |
| 05/01/2013 | CN103071062A Traditional Chinese medicine for treating hypertension |
| 05/01/2013 | CN103071061A Medicine for treating cerebrovascular diseases and preparation method of same |
| 05/01/2013 | CN103071037A Traditional Chinese medicine for treating hypertension |
| 05/01/2013 | CN103071032A Herbal food therapy capsule and preparation method thereof |
| 05/01/2013 | CN103071027A Traditional Chinese medicine for treating congenital pulmonary arterio-venous fistula |
| 05/01/2013 | CN103071014A Preparation method of traditional Chinese medicine used for treating eales disease |
| 05/01/2013 | CN103071008A Hemorrhoid ointment |
| 05/01/2013 | CN103071003A Traditional Chinese medicine for promoting blood circulation, removing blood stasis and clearing and activating channels and collaterals |
| 05/01/2013 | CN103070958A Drug composition for curing haemorrhoids and preparing method thereof |
| 05/01/2013 | CN103070954A Traditional Chinese medicine powder for treating haemorrhoids and preparation method of same |
| 05/01/2013 | CN103070944A Chinese medicinal composition for preventing and treating dam postpartum syndrome and preparation method thereof |
| 05/01/2013 | CN103070943A Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
| 05/01/2013 | CN103070916A Preparation method and application of effective part of dracocephalum heterophyllum benth |
| 05/01/2013 | CN103070909A Radix notoginseng and astragalus mongholicus soft capsule and preparation method thereof |
| 05/01/2013 | CN103070898A Salvia miltiorrhiza and panax notoginseng compound nano suspension |
| 05/01/2013 | CN103070897A Traditional Chinese medicine composition used for treating coronary heart disease, and preparation method thereof |
| 05/01/2013 | CN103070891A Capsule containing Hypericum perforatum extract |
| 05/01/2013 | CN103070873A Pharmaceutical composition for treating hemorrhoid and use thereof |
| 05/01/2013 | CN103070863A Novel preparation process for oral solid preparation of aliskiren and amlodipine/levamlodipine |
| 05/01/2013 | CN103070861A Pharmaceutical composition and application of same in preparation of medicines used for treating cerebrovascular diseases |
| 05/01/2013 | CN103070853A Use of ethyl pyruvate in drug preparation |